In gratitude of the loyal support of our members, the CNS is offering complimentary 2021 Annual Meeting registration to all members! Learn more.

  • Does Insurance Status Affect Outcomes in Glioblastoma Multiforme Patients?

    Final Number:
    1663

    Authors:
    Shihao Zhang MD; Justin Haydel MD; Bharat Guthikonda MD; Anil Nanda MD, FACS

    Study Design:
    Other

    Subject Category:

    Meeting: Congress of Neurological Surgeons 2015 Annual Meeting

    Introduction: Glioblastoma Multiforme (GBM) is the most aggressive primary malignant brain tumor. Less than 3% of patients greater than the age of 65 are alive two years after diagnosis. Patients regardless of insurance status diagnosed with GBM are referred to LSUHSC – Shreveport, a tertiary center for neurosurgery, for treatment. This study aims to determine if there is any difference in time to treatment and tumor recurrence among patients with different insurance statuses.

    Methods: We retrospectively analyzed the medical records of 111 patients with tissue diagnosis of glioblastoma multiforme from January 2010 to January 2013. Patients were sorted by three categories: uninsured, Medicare, and commercial insurance. Tumor recurrence is defined by either brain biopsy or clinical / radiographic follow-up. Time to treatment is the time from tissue diagnosis to chemo/radiation treatment.

    Results: Out of 111 patients, 70 patients were male. 25 patients did not have insurance on admission, 30 patients had commercial insurance, and 56 patients had Medicare. Medicare patients were older than the other groups, the average age being 63.6. Uninsured patients’ average age was 46.2, while commercial insurance average age was 52.8. Time to recurrence for uninsured patients was 11.1 months, commercial insurance was 14.8 months, and Medicare was 14.5 months. Time to treatment for uninsured patients was 23.5 days, commercial insurance was 22.7 days, and Medicare was 27.2 days.

    Conclusions: There was no significant difference in time to treatment for uninsured patients as compared to patients with commercial or Medicare insurance in our institution. Uninsured patients did have quicker tumor recurrence than the other two groups.

    Patient Care: To understand health disparities in the US health care system.

    Learning Objectives: To determine if there is difference in outcome in patients without insurance.

    References:

We use cookies to improve the performance of our site, to analyze the traffic to our site, and to personalize your experience of the site. You can control cookies through your browser settings. Please find more information on the cookies used on our site. Privacy Policy